Aardvark Therapeutics, Inc.
AARD · NASDAQ · USD
$4.71
−0.25 −5.04%todayNot financial advice.
- Open
- 4.77
- Day range
- 4.57 - 5.09
- 52-week range
- 3.35 - 17.06
- Volume
- 315.97K
- Market cap
- 103.08M
- P/E ratio
- —
- EPS
- -3.21
- Dividend yield
- 0.00%
- Beta
- 3.61
Performance
W
−10.96%
1M
−11.63%
3M
−6.36%
6M
+20.15%
YTD
−64.59%
Y
−72.52%
5Y
−68.97%
All
−68.97%
In the news
Oct 8
Aardvark Therapeutics Names Regulatory Expert David Zhang to Board
Aardvark Therapeutics appointed regulatory expert David Zhang to its board as its lead drug candidate ARD-101 faces an FDA clinical hold.
Company news
Oct 8
Aardvark Therapeutics Appoints David Zhang to Board of Directors
Aardvark Therapeutics has appointed clinical development veteran David Zhang to its board to help guide ARD-101 through regulatory pathways.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-AARD" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Aardvark Therapeutics, Inc. (AARD) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-AARD">AARD stock price</a> by FreeTheAI Stocks</p>